Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Small Molecule Drug Discovery Market CAGR Outlook And Future Development
The market for small molecule drug discovery has seen rapid expansion in recent years. It is projected to grow from $67.94 billion in 2025 to $75.56 billion in 2026, at a compound annual growth rate (CAGR) of 11.2%. This historical growth can be attributed to increased R&D investments by pharmaceutical companies, a rise in chronic disease prevalence, advancements in molecular biology techniques, a growing demand for cost-effective therapeutics, and the emergence of contract research organizations (CROs).
The small molecule drug discovery market is projected to experience substantial expansion over the upcoming years. It is anticipated to reach $117.05 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 11.6%. This anticipated growth during the prediction period stems from factors such as the incorporation of AI and machine learning into drug discovery processes, the broadening scope of precision medicine efforts, heightened collaboration between biotechnology and pharmaceutical firms, the implementation of automated high-throughput systems, and an intensifying focus on addressing rare and intricate diseases. Key developments foreseen in this period encompass the uptake of high-throughput screening, progress in combinatorial chemistry, the incorporation of nanotechnology into drug design, the evolution of personalized medicine, and improvements in target validation and lead optimization.
Get A Free Sample Report With In-Depth Market Insights:
Small Molecule Drug Discovery Market Demand Drivers Opening New Revenue Streams
The increasing prevalence of chronic illnesses is anticipated to propel the expansion of the small molecule drug discovery market. Chronic diseases are defined as conditions persisting for a year or more, impeding daily activities, necessitating ongoing medical attention, or a combination thereof. Small-molecule medications effectively address various chronic conditions, including HIV, cancer, infections, heart disease, and renal disease, and are typically more cost-effective for individuals managing such long-term health issues. Consequently, the growing occurrence of chronic diseases is expected to stimulate the small molecule drug discovery market. For instance, a 2023 report from the National Institutes of Health (NIH), a US-based biomedical research agency, indicates that the number of Americans aged 50 and older living with at least one chronic illness is projected to reach 142.66 million by 2050. Furthermore, the population experiencing multimorbidity is forecast to increase to 14.968 million by the same year. Hence, the rising incidence of chronic diseases is a key driver for the growth of the small molecule drug discovery market.
Small Molecule Drug Discovery Market Segment Breakdown: Which Categories Lead On Revenue?
The small molecule drug discovery market covered in this report is segmented –
1) By Drug Type: Small Molecule Drugs, Biologic Drugs
2) By Technology: High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology, Others
3) By Therapeutic Area: Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, Others
4) By Process Or Phase: Target ID Or Validation, Hit Generation And Selection, Lead Identification, Lead Optimization
5) By End-User: Pharmaceutical Companies, Contract Research Organizations, Others
Subsegments:
1) By Small Molecule Drugs: Generic Small Molecule Drugs, Novel Small Molecule Drugs
2) By Biologic Drugs: Monoclonal Antibodies, Vaccines, Recombinant Proteins, Cell And Gene Therapies
Small Molecule Drug Discovery Market Trends Powering Strategic Industry Growth
Key companies within the small molecule drug discovery sector are forming alliances to boost their market revenues. Collaborations frequently encourage innovation by uniting the specialized knowledge of various organizations. For example, in November 2023, Evommune, a US-based non-profit organization, and Accutar Biotechnology, a US-based biotechnology company, revealed a strategic partnership focused on AI-based drug discovery, specifically targeting chronic inflammatory diseases. This joint effort seeks to utilize Accutar’s proprietary AI platform and Evommune’s expertise to uncover novel small molecule drug candidates.
Small Molecule Drug Discovery Market Leading Players And Competitive Positioning
Major companies operating in the small molecule drug discovery market are Pfizer Inc., GlaxoSmithKline plc, AstraZeneca, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, Gilead Sciences Inc., Merck KGaA, Novartis AG, 4SC AG, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Labcorp Drug Development, ICON Public Limited Company, Charles River Laboratories, Aluda Pharmaceuticals, Corcept Therapeutics, Edison Oncology, Escend Pharmaceuticals, Terray Therapeutics, Apollomics, Astex Pharmaceuticals, Pardes Biosciences, Xynomic Pharmaceuticals, Zevra Therapeutics, UNION therapeutics, Allarity Therapeutics, Cyteir Therapeutics, BigHat Biosciences
View The Full Small Molecule Drug Discovery Market Report:
Small Molecule Drug Discovery Market Regional Analysis And Leading Geography
North America was the largest region in the small molecule drug discovery market in 2025. Europe is expected to be the fastest-growing region in the small molecule drug discovery market report during the forecast period. The regions covered in the small molecule drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
